The ISC Board has made class 12th syllabus available for the academic year 2026-27. In this article we have explained the biology syllabus for class 12th students. They can check this article and ...
AI solutions for Automotive, Aerospace, and Industrial Heavy Machinery industries Eligibility: Engineering students in the third and fourth year of B.E. or B.Tech programmes in India Viasat Inc has ...
The University of Minnesota’s Board of Regents on Friday approved a $5.4 billion operating budget for the U system that ...
The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total hip bone mineral density (BMD) at Month 12, would support Entera's plan to submi ...
Novo Nordisk A/S outlook: 2026 guidance warns revenue/profit declines as GLP-1 competition, pricing pressure & patent risks ...
China is increasingly embracing the mantle that comes with being a global superpower. Its rise is forcing the rest of the world to assess its credentials as a potential hegemon and a provider of ...
New Cobalt Research Reveals Only 9% of Security Professionals Support Fully Automated PentestingSAN FRANCISCO--(BUSINESS WIRE ...
It can serve as a catalyst for growth. Greece cannot afford to wait. It must invest, accelerate, and take bold steps,” ...
Unaudited Financial Results for the First Quarter of 2026 Total revenues were RMB25.7 million (US$3.7 million), compared with RMB26.1 million in the first quarter of 2025, and RMB177.6 million in the ...
Entera Bio (NASDAQ:ENTX) has been pursuing that same vision in osteoporosis, and this morning the company announced what may be the most significant regulatory milestone in its history. Entera ...
The London Stock Exchange (LSE) has set out significant proposed reforms to the AIM Rules for Companies (AIM Rules), with the important aim ...
At the big endocrinology meetings this season, one story kept stealing the room: the pill that turned an injectable blockbuster into the fastest-moving launch in modern pharma. Novo Nordisk’s oral ...